Search for: "CIPLA" Results 21 - 40 of 202
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Sep 2011, 6:22 am by Marty Schwimmer
Plaintiff alleges that Indian generic pharma CIPLA (covertly) manufactures DA DOUBLE ADVANTAGE and conspires to sell it into the US through several offshore websites. [read post]
23 Apr 2014, 9:59 pm by Patent Docs
Cipla Ltd. et al. 1:14-cv-00427; filed April 7, 2014 in the District Court of Delaware • Plaintiffs: Helsinn Healthcare S.A.; Roche Palo Alto LLC • Defendants: Cipla Ltd.; Cipla USA Inc. [read post]
18 Feb 2013, 7:00 pm by Prashant Reddy
Cipla produced a long list of documents which had not been submitted to the Patent Office under Section 8 of the Patent Act and the Patentee argued against this proposition by relying on an interpretation of various precedents of the IPAB and the High Courts. [read post]
19 Mar 2008, 2:04 am by GenericIPguy
"The Delhi High Court has NOT granted an injunction against Cipla to Roche for Erlotinib [Tarceva (R) ]. [read post]
20 Jul 2010, 12:20 am by GenericIPguy
Friends from Delhi have the following update:a) The Bayer / Cipla Sorafenib patent infringement suit at the Delhi High Court will be next heard on 23rd July, 2010.b) The Bayer/ Cipla Sorafenib/ Patent linkage case at the Supreme Court will be next heard on 03rd August, 2010.c) The Roche/ Natco Erlotinib infringement suit at the Delhi High Court will be heard on a daily basis, from 27th July, 2010 [read post]
9 Jul 2008, 3:46 pm
This business strategy not only made Cipla a preferred choice for cheap generic drugs but also transformed into Billion Dollar Company. [read post]
28 Apr 2009, 10:04 am by VC
In December 2008, the Delhi Patent Office rejected OSI Pharmaceuticals patent application number IN/PCT/2002/507/DEL for polymorph B form of erlotinib hydrochloride in a pre-grant opposition proceeding filed by Cipla. [read post]
28 Apr 2009, 10:04 am by VC
IN/PCT/2002/507/DEL for polymorph B form of erlotinib hydrochloride in a pre-grant opposition proceeding filed by Cipla. [read post]
30 Mar 2012, 6:48 pm by Mark Zamora
Sun Pharmaceuticals is recalling about 155,000 bottles of an eye solution, while two of Cipla's top pharma partners have pulled products made at its Goa plant.Read more: Drugs made by Sun Pharma, Cipla recalled in U.S. - FiercePharma http://www.fiercepharma.com/story/drugs-made-sun-pharma-cipla-recalled-us/2012-03-29#ixzz1qeeymDe5 http://articles.economictimes.indiatimes.com/2012-03-29/news/31254546_1_fda-s-class-iii-bottles-cancer-drug  [read post]
14 Jul 2008, 3:12 pm
It seems to be like Erlotinib (Tarceva), Cipla will again go ahead disrespecting patents for other anti-cancer drugs. [read post]
25 Jan 2012, 12:54 pm by Marty Schwimmer
Issues re Non-US Online Infringement Litigation Domain Name In Rem: Decker v 2011cheapuggs.com, (ED Va Jan 6, 2012) Order. [read post]